BridgeBio Oncology Therapeutics, Inc. (BBOT): 10-Q filed May 12, 2026

Form type
10-Q
Filing date
May 12, 2026
Accession number
0001193125-26-219829
Filer
BridgeBio Oncology Therapeutics, Inc. (CIK 1869105)